三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图表50F-star双特异性抗体双抗结构示意
图表50F-star双特异性抗体双抗结构示意
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:283KB
图片尺寸:1112*624
同报告图片
/
4
fCDmlbDmja7nsbvlnosgfCDmj4/ov7AgfAp8IC0tLSB8IC0tLSB8Cnwg6Ieq54S257uT5ZCI5L2N54K5IHwgMuS4quiHqueEtue7k+WQiOS9jeeCuSB8CnwgRmPOs1Ig56qB5Y+YIHwg5pS55ZaE5a6J5YWo5oCn5r2c5YqbIHwKfCDmlrBGY+aKl+WOn+e7k+WQiOS9jeeCuSB8IDLkuKrmlrBGY+aKl+WOn+e7k+WQiOS9jeeCuSB8CgoqKui1hOaWmeadpea6kO+8muWFrOWPuOWumOe9ke+8jOW5s+WuieivgeWIuOeglOeptuaJgCoq
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
所属报告:
中国生物制药-港股公司研究报告:百亿单品可期四大板块并进创新+国际化双轮驱动-241008(31页).pdf
打包全文图表
相关数据
图表20PFA具备较强的组织选择特异性
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
收藏
行业数据
2026-06-26
原图定位
查看详情
TRiM™能将RNAi特异性地递送到不同组织中,实现治疗不同类型疾病的目的
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
收藏
行业数据
2025-09-28
原图定位
查看详情
TRiM™能将RNAi特异性地递送到不同组织中,实现治疗不同类型疾病的目的
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
收藏
行业数据
2025-09-28
原图定位
查看详情
同类药物的器官特异性应答率,TQ05105应答率最优(非头对头)
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
收藏
行业数据
2025-09-24
原图定位
查看详情
同类药物的器官特异性应答率,TQ05105应答率最优(非头对头)
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
收藏
行业数据
2025-09-24
原图定位
查看详情
图21、F-Star对外商务合作项目进展(截至2023年3月)
PHxiZWdpbl9vZl9ib3h8Pnwg5ZCI5L2c5pa5ICAgICAgICAgICAgICAgfCDpobnnm67nsbvlnosgICAgICAgICAgICAgICAgICAgICB8IOaXtumXtCAgICAgICAgIHwg5YWz6ZSu5p2h5qy+ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBUYWtlZGEgICAgICAgICAgICAgIHwg5YWN55ar6IK/55ik6aG555uu77yI5byA5Y+RMuS4quWPjOaKl+WIhuWtkO+8iSB8IDIwMjLlubQ35pyIICAgIHwg6aaW5LuY5qy+77yaMTAw5LiH576O5YWD77yb56CU5Y+R5Y+K5ZWG5Lia5YyW6YeM56iL56KR77yafjQwMDDkuIfnvo7lhYPvvJvkuKrkvY3mlbDmj5DmiJAgICAgICAgICAgIHwKfCBUYWtlZGEgICAgICAgICAgICAgIHwg5YWN55ar6IK/55ik6aG555uu77yI5byA5Y+RMuS4quWPjOaKl+WIhuWtkO+8iSB8IDIwMjPlubQz5pyIICAgIHwg6aaW5LuY5qy+44CB6YeM56iL56KR44CB5o+Q5oiQICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgSmFuc3NlbiAgICAgICAgICAgICB8IOW8gOWPkeacgOWkmjXkuKrlj4zmipfkuqflk4EgICAgICAgICAgIHwgMjAyMeW5tDEw5pyIICAgfCDmvZzlnKjph4znqIvnopHvvJrmnIDlpJoxMy415Lq/576O5YWD77yb5o+Q5oiQICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgQXN0cmFaZW5lY2EgICAgICAgICB8IFNUSU5H5ouu5oqX5YmC77yI5byA5Y+R5paw5Z6L5Li05bqK5YmNU1RJTkfmi67mipfliYLnmoTni6zlrrbmnYPnm4rvvIkgfCAyMDIx5bm0N+aciCAgICB8IOa9nOWcqOmHjOeoi+eike+8muacgOWkmjYzMDDkuIfnvo7lhYPvvJvmj5DmiJAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgTWVyY2sgS0dhQSwgRGFybXN0YWR0fCDlhY3nlqvogr/nmKTlrabpobnnm67vvIjlvIDlj5HmnIDlpJoz5Liq5Y+M5oqX5YiG5a2Q77yJIHwgMjAyMOW5tDfmnIgvMjAxOeW5tDXmnIggfCDmvZzlnKjph4znqIvnopHvvJrmnIDlpJo3LjY25Lq/576O5YWD77yb5o+Q5oiQICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CgrmlbDmja7mnaXmupDvvJrlhazlj7jlhazlkYrvvIzlhbTkuJror4HliLjnu4/mtY7kuI7ph5Hono3noJTnqbbpmaLmlbTnkIY8fGVuZF9vZl9ib3h8Pg==
收藏
行业数据
2025-08-19
原图定位
查看详情
表21、EGFR、c-Met多特异性抗体全球竞争格局(临床阶段)
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
收藏
竞争格局
2025-07-24
原图定位
查看详情
表4、B细胞血液瘤CD3多特异性抗体全球竞争格局
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
收藏
竞争格局
2025-07-24
原图定位
查看详情
图表100Star-3Alpha大模型与MidjourneyV6.1、Dalle-3、Flux.1Dev评测比较
fCAgfCBTdGFyLTMgQWxwaGEgfCBNaWRqb3VybmV5IFY2LjEgfCBEYWxsZS0zIHwgRmx1eC4xRGV2IHwKfC0tLXwtLS18LS0tfC0tLXwtLS18CnwgVmVyc2F0aWxlIFN0eWxlcyB8IDc1LjgxIHwgNzIuODUgfCA1OC41NCB8IDYyLjAyIHwKfCBBbGlnbm1lbnQgfCA3Mi45OCB8IDc5Ljg5IHwgNTkuMjIgfCA2MS44OSB8CnwgQWVzdGhldGljIHwgNzcuNDEgfCA3Ni43OCB8IDU0Ljg2IHwgNTYuNzggfAp8IE92ZXJhbGwgfCA3NS40MCB8IDc2LjUxIHwgNTcuNTQgfCA2MC4wNCB8CgrotYTmlpnmnaXmupDvvJpMaWJsaWJBSeWumOe9ke+8jOWNjuWuieivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-07-16
原图定位
查看详情
图4、与PROTAC相关的具有组织分布特异性的E3连接酶
fCBFM+i/nuaOpemFtuexu+WeiyB8IEUz6L+e5o6l6YW256S65L6LIHwKfCAtLS0gfCAtLS0gfAp8IENOUy1lbnJpY2hlZCBFM3MgfCBUUklNOSwgUk5GMTgyLCBNYW55IG90aGVycyB8CnwgVHVtb3VyLWVucmljaGVkIEUzcyB8IERDQUYyLCBUUklNNzEsIE1BR0VzLCBNYW55IG90aGVycyB8CnwgTXVzY2xlLWVucmljaGVkIEUzcyB8IEtMSEw0MSwgS0xITDQwIHwKfCBVYmlxdWl0b3VzIEUzcyB8IENVTDRCLCBWSEwsIEdJRDQsIE1hbnkgb3RoZXJzIHwKCui1hOaWmeadpea6kO+8mkLDqWvDqXMgTSwgTGFuZ2xleSBEUiwgQ3Jld3MgQ00uIFBST1RBQyB0YXJnZXRlZCBwcm90ZWluIGRlZ3JhZGVyczogdGhl
收藏
行业数据
2025-05-23
原图定位
查看详情
SI-B001是一种靶向EGFR及HER3的四价双特异性抗体
fCDmipdFR0ZSIHwg5oqXSEVSMyB8IHd0IEZjIGxnRzEgfAp8LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfAp8IOe6ouiJsuaWueWdlyB8IOiTneiJsuaWueWdlyB8IOeBsOiJsuaWueWdlyAgICB8
收藏
行业数据
2025-04-14
原图定位
查看详情
611治疗特异性皮炎的EASI75及NRS优于度普利尤单抗(II期数据)
fCBDb21wYW55IHwgSW5kaWNhdGlvbiB8IENvZGUgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgQSB8IEFEIGFwcHJvdmVkIHwgIHwKfCBCIHwgQXN0aG1hIE5EQSByZXZpZXdpbmcgfCAgfAp8IDNTQmlvIHwgQXN0aG1hIFBoYXNlIElJIGNvbXBsZXRlZCB8ICB8CnwgIHwgQUQgUGhhc2UgSUlJIHwgIHwKfCAgfCBDUlN3TlAgUGhhc2UgSUlJIHwgIHwKfCAgfCBDT1BEIFBoYXNlIElJIHwgIHwKfCAgfCBTU0dKLTYxMSB8ICB8CgrotYTmlpnmnaXmupDvvJrkuInnlJ/liLboja/lhazlj7jlrpjnvZHvvIzlm73nm5vor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-03-24
原图定位
查看详情
多特异性抗体与单抗和双特异性抗体的比较
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
收藏
行业数据
2025-02-06
原图定位
查看详情
全球进入临床阶段的多特异性抗体梳理
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
收藏
行业数据
2025-02-06
原图定位
查看详情
2015-2023年我国特异性免疫球蛋白产品批签发批次情况
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
收藏
行业数据
2024-12-03
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
核心在研管线步入临床阶段,差异化布局海外 BD可期。目前 F-star进入临床阶段的主要包括 3条核心在研管线:1)FS118:
行业数据
原图定位
当前图表所属:
中国生物制药-港股公司研究报告:百亿单品可期四大板块并进创新+国际化双轮驱动-241008(31页).pdf
图表92023年同类可比公司销售人员数量对比(人)
图表82018-2024H1公司期间费用率(%)
图表72018-2024H1公司销售毛利率和持续经营业务
图表6中国生物制药2018-2024H1经调归母净利润及
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》